As life expectancies increase, RealMoney Pro contributor Chris Versace reveals ways investors can play the aging U.S. population.
Dow component UnitedHealth also gains on the Affordable Care Act, but CNO Financial and WellCare fell short of earnings estimates and pulled back.
Investors will get a first look at data from an early stage study of an Applied Genetic therapy on Friday.
U.S. stock futures trade mixed; Apple is expected to release a new iPhone on Tuesday; Home Depot confirms a data breach; General Mills to buy Annie's.
Who cares about J&J's sluggish medical devices business when it has such a strong drug pipeline and balance sheet?
These shares are still too expensive for new investors.
U.S. stock futures point lower; Alibaba begins IPO roadshow; Electrolux to buy GE's appliances business; Boeing and Ryanair to make fleet announcement.
Missing anemia benefit from "Zerenex" label makes Keryx's phosphate binder a tough sell.
Allergan's management and its board are right to resist Bill Ackman's bid and protect the interest of shareholders.
Wall Street is wrong to discount Baxter's value-creating potential.
By Brian O'Connell
That number rises the further you slide down the income scale, too, with 44% Americans earning less than $30,000 a year having more
Biotech columnist Adam Feuerstein answers readers' questions about health care.
U.S. stock futures fall ahead of U.J. jobs report; MetLife could receive stricter oversight; Tesla 'gigafactory' to be built in suburb of Reno, Nev.
The company has a potential life-saving catalyst in its portfolio, too.
There's no compelling reason to buy this stock above $40.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV